Last updated: 2026-09-04 22:34:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Quest Diagnostics Inc. (DGX) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NYSE. The stock is currently priced at $237.08, with a market capitalization of $26.58B and a P/E ratio of 24.95. Over the past 52 weeks, its price has ranged from $171.18 to $247.19. This page covers its latest market performance, valuation, price trends and company information.
$26.58B | |
$235.38 | |
$247.19 | |
$29.74 | |
$239.40 | |
594.57K | |
-- | |
24.95 | |
$247.19 | |
$171.18 | |
1.56% | |
-- |
Quest Diagnostics Inc. (DGX) is trading at $241.60 in after-hours trading as of 2026-09-04 22:25:00, up 0.92% ($2.20) from the regular-session close of $239.40.
After-hours trading shows how investors are pricing DGX after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, Quest Diagnostics Inc. (DGX) moved from $241.99 to $237.08, representing a decline of 2.03% ($4.91).
The stock traded between $235.38 and $239.17 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 948.24 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 86.7%
DGX is currently trading at $237.08, placing it 86.7% of the way from its 52-week low of $171.18 to its 52-week high of $247.19. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 57000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Quest Diagnostics Inc. (DGX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.